BioLife Solutions (BLFS) Misses Q4 EPS by 20c
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $35.71 +1.30%
EPS Growth %: +400.0%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +400.0%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.37), $0.20 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $37.3 million versus the consensus estimate of $35.81 million.
GUIDANCE:
BioLife Solutions sees FY2022 revenue of $159.5-171 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- JPMorgan starts FedEx Freight at Overweight on post-spin turnaround
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
